Duncan M, Grant G. Oral and intestinal mucositis—causes and
possible treatments. Aliment Pharmacol Ther.2003
;18:853
-874.
3.
Takasuna K, Hagiwara T, Watanabe K, et al. Optimal antidiarrhea
treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced
delayed diarrhea. Cancer Chemother Pharmacol.2006
:58:494
-503.
4.
Arbuckle RB, Huber SL, Zacker C. The consequences of diarrhea
occurring during chemotherapy for colorectal cancer: a retrospective study.
Oncologist.2000
;5:250
-259.
5.
Dranitsaris G, Maroun J, Shah A. Estimating the cost of illness in
colorectal cancer patients who were hospitalized for severe
chemotherapy-induced diarrhea. Can J Gastroenterol.2005
;19:83
-87.
6.
Von Bültzingslöwen I, Adlerberth I, Wold AE,
Dahlén G, Jontell M. Oral and intestinal microflora in 5-fluorouracil
treated rats, translocation to cervical and mesenteric lymph nodes and effects
of probiotic bacteria. Oral Microbiol Immunol.2003
;18:278
-284.
Österlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus
supplementation for diarrhoea related to chemotherapy of colorectal cancer: a
randomised study. Br J Cancer.2007
;97:1028
-1034.
Abd El-Atti S, Wasicek K, Mark S, Hegazi R. The usage of probiotics
in the management of chemotherapy induced diarrhea: a case study
JPEN J Parenter Enteral Nutr. IN PRESS: doi:10.1177/0148607109332004
.
